Role of Pregnane X Receptor in Obesity and Glucose Homeostasis in male mice

Journal of Biological Chemistry

Volumn 289, Issue 6, 2014, Pages 3244-3261

  Spruiell, Krisstonia ^a   Richardson, Ricardo M ^a   Cullen, John M ^b   Awumey, Emmanuel M ^a   Gonzalez, Frank J ^c   Gyamfi, Maxwell A ^a  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES; METABOLIC SYNDROME; NUCLEAR RECEPTORS; OBESITY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR);

ADIPOSE TISSUE; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOKINASE; GLUCOSE; HEPATOMEGALY; HUMANS; HYPERINSULINISM; LIVER; MALE; MICE; MICE, KNOCKOUT; OBESITY; PPAR ALPHA; RECEPTORS, STEROID; SPECIES SPECIFICITY;

EID: 84893704164     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.494575     Document Type: Article

References (71)

1. Hedley, A. A., Ogden, C. L., Johnson, C. L., Carroll, M. D., Curtin, L. R., and Flegal, K. M. (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291, 2847-2850
2. Astrup, A., Buemann, B., Western, P., Toubro, S., Raben, A., and Christensen, N. J. (1994) Obesity as an adaptation to a high-fat diet. Evidence from a cross-sectional study. Am. J. Clin. Nutr. 59, 350-355
3. Bell, C. G., Walley, A. J., and Froguel, P. (2005) The genetics of human obesity. Nat. Rev. Genet. 6, 221-234
4. Chawla, A., Repa, J. J., Evans, R. M., and Mangelsdorf, D. J. (2001) Nuclear receptors and lipid physiology. Opening the X-files. Science 294, 1866-1870
5. Berger, J., and Moller, D. E. (2002) The mechanisms of action of PPARs. Annu. Rev. Med. 53, 409-435
6. Wang, Y. X., Lee, C. H., Tiep, S., Yu, R. T., Ham, J., Kang, H., and Evans, R. M. (2003) Peroxisome-proliferator-Activated receptor delta activates fat metabolism to prevent obesity. Cell 113, 159-170
7. Gao, J., and Xie, W. (2010) Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism. Drug Metab. Dispos. 38, 2091-2095
8. Nakamura, K., Moore, R., Negishi, M., and Sueyoshi, T. (2007) Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver. J. Biol. Chem. 282, 9768-9776
9. Bertilsson, G., Heidrich, J., Svensson, K., Asman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., and Berkenstam, A. (1998) Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc. Natl. Acad. Sci. U.S.A. 95, 12208-12213
10. Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., Willson, T. M., Koller, B. H., and Kliewer, S. A. (2001) The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U.S.A. 98, 3369-3374
11. Carr, A., Samaras, K., Chisholm, D. J., and Cooper, D. A. (1998) Pathogenesis of HIV-1-protease inhibitor-Associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351, 1881-1883
12. Dussault, I., Lin, M., Hollister, K., Wang, E. H., Synold, T. W., and Forman, B. M. (2001) Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR. J. Biol. Chem. 276, 33309-33312
13. Kodama, S., Koike, C., Negishi, M., and Yamamoto, Y. (2004) Nuclear receptors CAR and PXR cross-talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol. Cell. Biol. 24, 7931-7940
14. Kodama, S., Moore, R., Yamamoto, Y., and Negishi, M. (2007) Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochem. J. 407, 373-381
15. Chiang, J. Y. (2002) Bile acid regulation of gene expression. roles of nuclear hormone receptors. Endocr. Rev. 23, 443-463
16. Sonoda, J., Chong, L. W., Downes, M., Barish, G. D., Coulter, S., Liddle, C., Lee, C. H., and Evans, R. M. (2005) Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites. Proc. Natl. Acad. Sci. U.S.A. 102, 2198-2203
17. Sookoian, S., Castaño, G. O., Burgueño, A. L., Gianotti, T. F., Rosselli, M. S., and Pirola, C. J. (2010) The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease. Pharmacogenet. Genomics 20, 1-8
18. Zhang, H., LeCulyse, E., Liu, L., Hu, M., Matoney, L., Zhu, W., and Yan, B. (1999) Rat pregnane X receptor. Molecular cloning, tissue distribution, and xenobiotic regulation. Arch. Biochem. Biophys. 368, 14-22
19. He, J., Gao, J., Xu, M., Ren, S., Stefanovic-Racic, M., O'Doherty, R. M., and Xie, W. (2013) PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice. Diabetes 62, 1876-1887
20. Ma, Y., and Liu, D. (2012) Activation of pregnane X receptor by pregnenolone 16-carbonitrile prevents high-fat diet-induced obesity in AKR/J Mice. PLoS ONE 7, e38734
21. Xie, W., Barwick, J. L., Downes, M., Blumberg, B., Simon, C. M., Nelson, M. C., Neuschwander-Tetri, B. A., Brunt, E. M., Guzelian, P. S., and Evans, R. M. (2000) Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406, 435-439
22. Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., and Kliewer, S. A. (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016-1023
23. Blumberg, B., Sabbagh, W., Jr., Juguilon, H., Bolado, J., Jr., van Meter, C. M., Ong, E. S., and Evans, R. M. (1998) SXR, a novel steroid and xeno-biotic-sensing nuclear receptor. Genes Dev. 12, 3195-3205
24. Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C., LeCluyse, E. L., Lambert, M. H., Willson, T. M., Kliewer, S. A., and Moore, J. T. (2000) The pregnane X receptor. A promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol. 14, 27-39
25. Ma, X., Shah, Y., Cheung, C., Guo, G. L., Feigenbaum, L., Krausz, K. W., Idle, J. R., and Gonzalez, F. J. (2007) The PREgnane X receptor genehumanized mouse. A model for investigating drug-drug interactions mediated by cytochromes P450 3A. Drug Metab. Dispos. 35, 194-200
26. Parra, P., Bruni, G., Palou, A., and Serra, F. (2008) Dietary calcium attenuation of body fat gain during high-fat feeding in mice. J. Nutr. Biochem. 19, 109-117
27. Shemesh, T., Rowley, K. G., Shephard, M., Piers, L. S., and O'Dea, K. (2006) Agreement between laboratory results and on-site pathology testing using Bayer DCAand Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin. Chim. Acta 367, 69-76
28. Gyamfi, M. A., He, L., French, S. W., Damjanov, I., and Wan, Y. J. (2008) Hepatocyte retinoid X receptor-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury. J. Pharmacol. Exp. Ther. 324, 443-453
29. Gyamfi, M. A., Kocsis, M. G., He, L., Dai, G., Mendy, A. J., and Wan, Y. J. (2006) The role of retinoid X receptor-in regulating alcohol metabolism. J. Pharmacol. Exp. Ther. 319, 360-368
30. Gyamfi, M. A., Tanaka, Y., He, L., Klaassen, C. D., and Wan, Y. J. (2009) Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXR-null mice. Toxicol. Appl. Pharmacol. 234, 166-178
31. Tanaka, Y., Aleksunes, L. M., Yeager, R. L., Gyamfi, M. A., Esterly, N., Guo, G. L., and Klaassen, C. D. (2008) NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J. Pharmacol. Exp. Ther. 325, 655-664
32. Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., Perlmann, T., and Lehmann, J. M. (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73-82
33. Valls, C., Iannacconne, R., Alba, E., Murakami, T., Hori, M., Passariello, R., and Vilgrain, V. (2006) Fat in the liver. Diagnosis and characterization. Eur. Radiol. 16, 2292-2308
34. El-Haschimi, K., Pierroz, D. D., Hileman, S. M., Bjørbaek, C., and Flier, J. S. (2000) Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 105, 1827-1832
35. Lin, S., Thomas, T. C., Storlien, L. H., and Huang, X. F. (2000) Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int. J. Obes. Relat. Metab. Disord. 24, 639-646
36. Costa, A., Conget, I., and Gomis, R. (2002) Impaired glucose tolerance. Is there a case for pharmacologic intervention? Treat. Endocrinol. 1, 205-210
37. Pilkis, S. J., and Granner, D. K. (1992) Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Physiol. 54, 885-909
38. Memon, R. A., Tecott, L. H., Nonogaki, K., Beigneux, A., Moser, A. H., Grunfeld, C., and Feingold, K. R. (2000) Up-regulation of peroxisome proliferator-Activated receptors (PPAR-) and PPAR-messenger ribonucleic acid expression in the liver in murine obesity. Troglitazone induces expression of PPAR-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141, 4021-4031
39. Kroetz, D. L., Yook, P., Costet, P., Bianchi, P., and Pineau, T. (1998) Peroxisome proliferator-Activated receptor-controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J. Biol. Chem. 273, 31581-31589
40. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., Ito, Y., Kamon, J., Tsuchida, A., Kumagai, K., Kozono, H., Hada, Y., Ogata, H., Tokuyama, K., Tsunoda, M., Ide, T., Murakami, K., Awazawa, M., Takamoto, I., Froguel, P., Hara, K., Tobe, K., Nagai, R., Ueki, K., and Kadowaki, T. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332-339
41. Kahn, B. B., Alquier, T., Carling, D., and Hardie, D. G. (2005) AMP-Activated protein kinase. Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15-25
42. Minokoshi, Y., Kim, Y. B., Peroni, O. D., Fryer, L. G., Müller, C., Carling, D., and Kahn, B. B. (2002) Leptin stimulates fatty-Acid oxidation by activating AMP-Activated protein kinase. Nature 415, 339-343
43. Birnbaum, M. J. (1989) Identification of a novel gene encoding an insulinresponsive glucose transporter protein. Cell 57, 305-315
44. Marette, A., Burdett, E., Douen, A., Vranic, M., and Klip, A. (1992) Insulin induces the translocation of GLUT4 from a unique intracellular organelle to transverse tubules in rat skeletal muscle. Diabetes 41, 1562-1569
45. Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., and Gonzalez, F. J. (1995) Targeted disruption of the-isoform of the peroxisome proliferator-Activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15, 3012-3022
46. Matthias, A., Ohlson, K. B., Fredriksson, J. M., Jacobsson, A., Nedergaard, J., and Cannon, B. (2000) Thermogenic responses in brown fat cells are fully UCP1-dependent. UCP2 or UCP3 do not substitute for UCP1 in adrenergically or fatty acid-induced thermogenesis. J. Biol. Chem. 275, 25073-25081
47. Grupe, A., Hultgren, B., Ryan, A., Ma, Y. H., Bauer, M., and Stewart, T. A. (1995) Transgenic knockouts reveal a critical requirement for pancreatic-cell glucokinase in maintaining glucose homeostasis. Cell 83, 69-78
48. Iynedjian, P. B., Pilot, P. R., Nouspikel, T., Milburn, J. L., Quaade, C., Hughes, S., Ucla, C., and Newgard, C. B. (1989) Differential expression and regulation of the glucokinase gene in liver and islets of Langerhans. Proc. Natl. Acad. Sci. U.S.A. 86, 7838-7842
49. Korach-André, M., Gao, J., Gounarides, J. S., Deacon, R., Islam, A., and Laurent, D. (2005) Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance. Am. J. Physiol. Endocrinol. Metab. 288, E106-E116
50. Butler, P. C., Kryshak, E. J., Schwenk, W. F., Haymond, M. W., and Rizza, R. A. (1990) Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants. Diabetes 39, 217-225
51. Korach-André, M., Archer, A., Gabbi, C., Barros, R. P., Pedrelli, M., Steffensen, K. R., Pettersson, A. T., Laurencikiene, J., Parini, P., and Gustafsson, J. A. (2011) Liver X receptors regulate de novo lipogenesis in a tissuespecific manner in C57BL/6 female mice. Am. J. Physiol. Endocrinol. Metab. 301, E210-E222
52. Lefterova, M. I., and Lazar, M. A. (2009) New developments in adipogenesis. Trends Endocrinol. Metab. 20, 107-114
53. Misra, P. (2008) AMP activated protein kinase. A next generation target for total metabolic control. Expert. Opin. Ther. Targets 12, 91-100
54. Misra, P., and Chakrabarti, R. (2007) The role of AMP kinase in diabetes. Indian J. Med. Res. 125, 389-398
55. Roth, A., Looser, R., Kaufmann, M., Blättler, S. M., Rencurel, F., Huang, W., Moore, D. D., and Meyer, U. A. (2008) Regulatory cross-talk between drug metabolismandlipidhomeostasis. ConstitutiveandrostanereceptorandpregnaneX receptor increase Insig-1 expression. Mol. Pharmacol. 73, 1282-1289
56. Zhou, J., Zhai, Y., Mu, Y., Gong, H., Uppal, H., Toma, D., Ren, S., Evans, R. M., and Xie, W. (2006) A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J. Biol. Chem. 281, 15013-15020
57. Cheng, J., Krausz, K. W., Tanaka, N., and Gonzalez, F. J. (2012) Chronic exposure to rifaximin causes hepatic steatosis in pregnane X receptorhumanized mice. Toxicol. Sci. 129, 456-468
58. Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., and Shan, B. (1999) Identification of a nuclear receptor for bile acids. Science 284, 1362-1365
59. Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., and Evans, R. M. (2001) An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. U.S.A. 98, 3375-3380
60. Ravussin, E., Pratley, R. E., Maffei, M., Wang, H., Friedman, J. M., Bennett, P. H., and Bogardus, C. (1997) Relatively low plasma leptin concentrations precede weight gain in Pima indians. Nat. Med. 3, 238-240
61. Surwit, R. S., Petro, A. E., Parekh, P., and Collins, S. (1997) Low plasma leptin in response to dietary fat in diabetes-And obesity-prone mice. Diabetes 46, 1516-1520
62. Collins, S., Kuhn, C. M., Petro, A. E., Swick, A. G., Chrunyk, B. A., and Surwit, R. S. (1996) Role of leptin in fat regulation. Nature 380, 677
63. Rothwell, N. J., and Stock, M. J. (1979) A role for brown adipose tissue in diet-induced thermogenesis. Nature 281, 31-35
64. Zammit, V. A. (1999) Carnitine acyltransferases. Functional significance of subcellular distribution and membrane topology. Prog. Lipid. Res. 38, 199-224
65. Fromenty, B., and Pessayre, D. (1995) Inhibition of mitochondrial- oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 67, 101-154
66. Oleszczuk, A., Spannbauer, M., Tannapfel, A., Blüher, M., Hengstler, J., Pietsch, U. C., Schuhmacher, A., Wittekind, C., Hauss, J. P., and Schön, M. R. (2007) Regenerative capacity differs between micro-And macrovesicular hepatic steatosis. Exp. Toxicol. Pathol. 59, 205-213
67. Burt, A. D., Mutton, A., and Day, C. P. (1998) Diagnosis and interpretation of steatosis and steatohepatitis. Semin. Diagn. Pathol. 15, 246-258
68. Fromenty, B., Grimbert, S., Mansouri, A., Beaugrand, M., Erlinger, S., Rötig, A., and Pessayre, D. (1995) Hepatic mitochondrial DNA deletion in alcoholics. Association with microvesicular steatosis. Gastroenterology 108, 193-200
69. George, J., and Liddle, C. (2008) Nonalcoholic fatty liver disease. Pathogenesis and potential for nuclear receptors as therapeutic targets. Mol. Pharm. 5, 49-59
70. Fan, C. Y., Pan, J., Chu, R., Lee, D., Kluckman, K. D., Usuda, N., Singh, I., Yeldandi, A. V., Rao, M. S., Maeda, N., and Reddy, J. K. (1996) Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J. Biol. Chem. 271, 24698-24710
71. Hashimoto, T., Fujita, T., Usuda, N., Cook, W., Qi, C., Peters, J. M., Gonzalez, F. J., Yeldandi, A. V., Rao, M. S., and Reddy, J. K. (1999) Peroxisomal and mitochondrial fatty acid-oxidation in mice nullizygous for both peroxisome proliferator-Activated receptor-And peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J. Biol. Chem. 274, 19228-19236